These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 21880982

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Effect of combining ACE inhibitor and statin in lupus-prone mice.
    Shimazu H, Kinoshita K, Hino S, Yano T, Kishimoto K, Nagare Y, Nozaki Y, Sugiyama M, Ikoma S, Funauchi M.
    Clin Immunol; 2010 Aug; 136(2):188-96. PubMed ID: 20403731
    [Abstract] [Full Text] [Related]

  • 23. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM, Turner JE, Paust HJ, Lindner M, Peters A, Heiss K, Velden J, Hopfer H, Fehr S, Krieger T, Meyer-Schwesinger C, Meyer TN, Helmchen U, Mittrücker HW, Stahl RA, Panzer U.
    J Immunol; 2009 Oct 01; 183(7):4693-704. PubMed ID: 19734217
    [Abstract] [Full Text] [Related]

  • 24. Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice.
    Sadanaga A, Nakashima H, Akahoshi M, Masutani K, Miyake K, Igawa T, Sugiyama N, Niiro H, Harada M.
    Arthritis Rheum; 2007 May 01; 56(5):1618-28. PubMed ID: 17469144
    [Abstract] [Full Text] [Related]

  • 25. Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation.
    Wu Y, He S, Bai B, Zhang L, Xue L, Lin Z, Yang X, Zhu F, He P, Tang W, Zuo J.
    Cell Mol Immunol; 2016 May 01; 13(3):379-90. PubMed ID: 25942599
    [Abstract] [Full Text] [Related]

  • 26. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus.
    Luo J, Niu X, Liu H, Zhang M, Chen M, Deng S.
    Mol Immunol; 2013 Dec 01; 56(4):574-82. PubMed ID: 23911415
    [Abstract] [Full Text] [Related]

  • 27. [Therapeutic effect of total glucosides of paeony on lupus nephritis in MRL/lpr mice].
    Ding ZX, Yang SF, Wu QF, Lu Y, Chen YY, Nie XL, Jie HY, Qi JM, Wang FS.
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Apr 01; 31(4):656-60. PubMed ID: 21515463
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist.
    Bao L, Osawe I, Puri T, Lambris JD, Haas M, Quigg RJ.
    Eur J Immunol; 2005 Aug 01; 35(8):2496-506. PubMed ID: 16052609
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.
    Anders HJ, Vielhauer V, Eis V, Linde Y, Kretzler M, Perez de Lema G, Strutz F, Bauer S, Rutz M, Wagner H, Gröne HJ, Schlöndorff D.
    FASEB J; 2004 Mar 01; 18(3):534-6. PubMed ID: 14734643
    [Abstract] [Full Text] [Related]

  • 32. Anti-prolactin treatment alleviates lupus conditions by regulating the JAK2-STAT3 pathway.
    Jiang Y, Chen H, Lin J, Pan J, Shen Y, Li Q.
    Clin Exp Pharmacol Physiol; 2023 Dec 01; 50(12):936-943. PubMed ID: 37727880
    [Abstract] [Full Text] [Related]

  • 33. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity.
    Chan OT, Madaio MP, Shlomchik MJ.
    J Immunol; 1999 Oct 01; 163(7):3592-6. PubMed ID: 10490951
    [Abstract] [Full Text] [Related]

  • 34. Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice.
    Hasegawa H, Kohno M, Sasaki M, Inoue A, Ito MR, Terada M, Hieshima K, Maruyama H, Miyazaki J, Yoshie O, Nose M, Fujita S.
    Arthritis Rheum; 2003 Sep 01; 48(9):2555-66. PubMed ID: 13130475
    [Abstract] [Full Text] [Related]

  • 35. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T, Yoshimoto T, Tsubura A, Matsuzawa A.
    Cell Immunol; 2001 Jun 15; 210(2):77-86. PubMed ID: 11520074
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Procyanidin B2 prevents lupus nephritis development in mice by inhibiting NLRP3 inflammasome activation.
    He J, Sun M, Tian S.
    Innate Immun; 2018 Jul 15; 24(5):307-315. PubMed ID: 29874961
    [Abstract] [Full Text] [Related]

  • 38. Reversing interleukin-2 inhibition mediated by anti-double-stranded DNA autoantibody ameliorates glomerulonephritis in MRL-lpr/lpr mice.
    Song YC, Tang SJ, Lee TP, Hung WC, Lin SC, Tsai CY, Ng WV, Wu MF, Sun KH.
    Arthritis Rheum; 2010 Aug 15; 62(8):2401-11. PubMed ID: 20506162
    [Abstract] [Full Text] [Related]

  • 39. The influence of silicone implantation on murine lupus in MRL lpr/lpr mice.
    Schaefer CJ, Wooley PH.
    J Rheumatol; 1999 Oct 15; 26(10):2215-21. PubMed ID: 10529143
    [Abstract] [Full Text] [Related]

  • 40. Treatment with testosterone or estradiol in melatonin treated females and males MRL/MpJ-Faslpr mice induces negative effects in developing systemic lupus erythematosus.
    Jimenez-Caliani AJ, Jimenez-Jorge S, Molinero P, Rubio A, Guerrero JM, Osuna C.
    J Pineal Res; 2008 Sep 15; 45(2):204-11. PubMed ID: 18507713
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.